In this study, the levels of CEA and ProGRP in the BALF of the patients with lung cancer were significantly higher than those of the control group, indicating that the levels of CEA and ProGRP were significantly increased in patients with lung cancer. The gene discussed is GRP; the disease is lung cancer.